Patriots head coach faced more questions than answers after Sunday’s loss, with an awkward vibe during Jerod Mayo’s press conference. Reporter Khari A. Thompson attempts to decipher the situation and looks forward to next week’s game. The post on Boston.com highlights the confusion and uncertainty surrounding the team’s performance and future prospects.
Full Article
Monthly weight loss drug helps people lose 20% of body weight, trial finds
Amgen's monthly weight loss drug MariTide demonstrated a 20% average body weight reduction in a phase 2 trial, positioning it as a potential competitor in the GLP-1 market dominated by Novo Nordisk and Eli Lilly. With added benefits like improved A1c levels and cardiovascular risk factors, MariTide aims for a phase 3 trial, highlighting advancements in diabetes and weight loss treatments. Need More Context? 🔎
Read more